Mary Ann Mathias, MD
Ophthalmology · Arlington Heights, ILNPI 1851510416
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $500 of the $566 with a category attached, or 88.4%. Johnson & Johnson Surgical Vision, Inc. accounts for 88.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $500 and has fallen 97.2% since, to $14 in 2023. That places this record below the midpoint for ophthalmology clinicians in IL, where the typical reported total is $1,164.
Across 5 payments — averaging $113.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$500
- Carl Zeiss Meditec AG$39
- Novartis$27
What the payments were for
- Consulting fees$50088%
- Food & beverage$275%
- Gifts$397%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 1 | $500 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Novartis | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$566 in reported general payments places this provider in the 35th percentile of 773 ophthalmology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 56 | $50,404 |
| XiidraLifitegrast | 32 | $29,801 |
| Restasis MultidoseCyclosporine | 29 | $29,346 |
| Cyclosporine | 46 | $11,359 |
| LumiganBimatoprost | 17 | $10,784 |
| Latanoprost | 279 | $4,883 |
| Timolol Maleate | 100 | $4,866 |
| Prednisolone Acetate | 104 | $4,771 |
| VyzultaLatanoprostene Bunod | 11 | $3,266 |
| CombiganBrimonidine Tartrate/Timolol | 11 | $2,216 |
| ValacyclovirValacyclovir Hcl | 30 | $1,512 |
| ErythromycinErythromycin Base | 131 | $1,292 |
| Brimonidine Tartrate | 44 | $946 |
| Doxycycline Hyclate | 31 | $883 |
| Ketorolac Tromethamine | 31 | $565 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Arlington Heights
- Christopher WoodArlington Heights$29K
- Seenu HariprasadChicago$2.3M
- Lisa NijmSpringfield$1.7M
- Kathleen MornoNorth Riverside$1.2M
- Veeral ShethOak Forest$716K
- James KatzDes Plaines$642K
- Mitchell JacksonLake Villa$584K
- David LubeckHomewood$575K
- Parag MajmudarHighland Park$451K
- Daniel OwensLombard$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.